The first trial of an http://www.thestar.com/news/ebola_virus.htmlEbolaEND vaccine has begun in West Africa, according to a television news report.
The test of the vaccine against the deadly disease is being conducted on three health workers in Mali, http://www.nbcnews.com/storyline/ebola-virus-outbreak/exclusive-first-ebola-vaccine-trial-starts-africa-n222266 NBC News reports.
The move it hailed as a welcome step that may help bring more health-care workers to West Africa to fight the outbreak.
“This is just the critical first step in a series of additional clinical trials that will have to be carried out to fully evaluate the promising vaccine,” Samba Sow, director general of the Centre for Vaccine Development in Mali, tells NBC News.
Reports say Ebola has infected more than 8,000 people but the World Health Organization says the toll is even higher.
The news report says further trials are planned for Gambia in the near future.
Meanwhile, the World Health Organization says it is finalizing the paperwork to take possession of 800 or so vials of an experimental Ebola vaccine donated by the Canadian government, The Canadian Press reports.
A WHO official says the legal agreement required for the global health agency to accept the vaccine is almost done and the vaccine should be shipped to Geneva next week.
Dr. Marie-Paule Kieny says the vaccine was left in Winnipeg while plans for clinical trials were being worked out because the vaccine could be stored safely there.
Kieny says researchers who will conduct clinical trials of the vaccine in Europe and Africa should be submitting their proposals to their regulatory agencies next week, which means they will soon need the vaccine.
These Phase 1 trials will determine if the vaccine is safe to give to people and how much vaccine is needed for each person.